3KW

(2E,5R)-5-(2-cyclohexylethyl)-2-imino-3-methyl-5-{[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl}imidazolidin-4-one

Created:	2014-09-08
Last modified:	2020-06-27

Find Related PDB Entry
1 entries where 3KW is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	73
Chiral Atom Count	3
Bond Count	77
Aromatic Bond Count	11

2D diagram of 3KW

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2E,5R)-5-(2-cyclohexylethyl)-2-imino-3-methyl-5-{[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl}imidazolidin-4-one
Systematic Name (OpenEye OEToolkits)	(5R)-2-azanylidene-5-(2-cyclohexylethyl)-3-methyl-5-[[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl]imidazolidin-4-one
Formula	C₂₈ H₃₉ N₅ O
Molecular Weight	461.642
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C1N(C(=[N@H])NC1(CC4CCCC(Nc2nc3c(cc2)cccc3)C4)CCC5CCCCC5)C
SMILES	CACTVS	3.385	CN1C(=N)N[C](CCC2CCCCC2)(C[CH]3CCC[CH](C3)Nc4ccc5ccccc5n4)C1=O
SMILES	OpenEye OEToolkits	1.7.6	CN1C(=O)C(NC1=N)(CCC2CCCCC2)CC3CCCC(C3)Nc4ccc5ccccc5n4
Canonical SMILES	CACTVS	3.385	CN1C(=N)N[C@](CCC2CCCCC2)(C[C@H]3CCC[C@H](C3)Nc4ccc5ccccc5n4)C1=O
Canonical SMILES	OpenEye OEToolkits	1.7.6	[H]/N=C/1\N[C@](C(=O)N1C)(CCC2CCCCC2)C[C@H]3CCC[C@H](C3)Nc4ccc5ccccc5n4
InChI	InChI	1.03	InChI=1S/C28H39N5O/c1-33-26(34)28(32-27(33)29,17-16-20-8-3-2-4-9-20)19-21-10-7-12-23(18-21)30-25-15-14-22-11-5-6-13-24(22)31-25/h5-6,11,13-15,20-21,23H,2-4,7-10,12,16-19H2,1H3,(H2,29,32)(H,30,31)/t21-,23+,28+/m0/s1
InChIKey	InChI	1.03	XBQKWFZOPAEITA-TWLCBMPQSA-N

Related Resource References

Resource Name	Reference
PubChem	11568842

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.